Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System Lymphoma.
| Published in: | Targeted Oncology Vol. 18; no. 6; pp. 941 - 953 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
Nov2023
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173766073&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 173766073 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17762596 47DQ jtl: Targeted Oncology issn: 17762596 maglogo: N pubinfo: dt: Nov2023 vid: 18 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 173766073 173072320 10.1007/s11523-023-01006-z 173766073 ppf: 941 ppct: 12 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System Lymphoma. aug: au: Wang, Ning Mo, Zhenxian Pan, Lu Zhou, Minhua Ye, Xiaolan Liu, Xinjian Cai, Xiong Qian, Changgeng Chen, Feili Xiong, Yan Fan, Fushun Li, Wenyu affil: Guangdong Provincial People's Hospital Affiliated to Southern Medical University, Guangdong Academy of Medical Sciences, No. 123 Huifu West Road, 510080, Guangzhou, Guangdong, China sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|